Zhenge Biotech

company

About

Zhenge Biotech is a macromolecular pharmaceutical contract development and manufacturing organisation.

  • 101 - 250

Details

Last Funding Type
Series C
Last Funding Money Raised
$100M
Industries
Biotechnology,Manufacturing,Pharmaceutical
Founded date
Nov 7, 2017
Number Of Employee
101 - 250
Operating Status
Active

Zhenge Biotech is a macromolecular pharmaceutical contract development and manufacturing organisation.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$100M ¥100M
Zhenge Biotech has raised a total of $100M ¥100M in funding over 2 rounds. Their latest funding was raised on Aug 18, 2022 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 18, 2022 Series C ¥100M 1 Detail
Jan 11, 2022 Series C $100M 2 Sofina Detail

Investors

Number of Lead Investors
Number of Investors
1
3
Zhenge Biotech is funded by 3 investors. Sofina and Sinopharm-CICC are the most recent investors.
Investor Name Lead Investor Funding Round
Sofina Yes Series C
Sinopharm-CICC Series C
Junxin Yingtai Investment Series C